Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).

Clinical trial NCT06431776 · RECRUITING

Trial details

NCT number: NCT06431776
Sponsor: Savara Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Autoimmune Pulmonary Alveolar Proteinosis

Start date: 2025-10-22
Primary completion: 2027-06-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.